EverSource Wealth Advisors’s Oric Pharmaceuticals ORIC Stock Holding History

EverSource Wealth Advisors’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10K	Buy	923 +625	+210%	+$5.67K	﹤0.01%	2912
2026 Q1	$3.78K	Buy	298 +6	+2%	+$68	﹤0.01%	3393
2025 Q4	$2.39K	Sell	292 -3	-1%	-$35	﹤0.01%	3435
2025 Q3	$3.54K	Buy	295 +3	+1%	+$32	﹤0.01%	3298
2025 Q2	$2.96K	Buy	292 +183	+168%	+$1.23K	﹤0.01%	3355
2025 Q1	$608	Buy	+109	New	+$953	﹤0.01%	3397

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EverSource Wealth Advisors's ORIC Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Oric Pharmaceuticals (ORIC) stake by 210% in Q2 2026, buying an estimated $5.67K and bringing the position to 923 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #2912.

EverSource Wealth Advisors first reported a position in ORIC in Q1 2025 and has held it in 6 quarters since. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

EverSource Wealth Advisors held 923 shares of Oric Pharmaceuticals worth $10K as of Q2 2026.
EverSource Wealth Advisors bought 625 Oric Pharmaceuticals shares in Q2 2026, an estimated $5.67K.
Oric Pharmaceuticals made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2912 holding.
EverSource Wealth Advisors first reported a position in Oric Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.